TABLE 2.
Distribution of Individual Annual Doses among Cohort Participantsa
| Total number of workers | Hp(10) (mSv) | Colon (mGy) | Lung (mGy) | RBM (mGy) | Breast (mGy) (women only) | |
|---|---|---|---|---|---|---|
| Cohort | (percentage of exposed workers) | Mean (median; IQR) | Mean (median; IQR) | Mean (median; IQR) | Mean (median; IQR) | Mean (median; IQR) |
| France | 59,003 (72%) | 0.93 (0.14; 0.00,0.96) | 0.64 (0.10; 0.00,0.66) | 0.64 (0.10; 0.00,0.66) | 0.59 (0.09; 0.00,0.61) | 0.21 (0.00; 0.00,0.08) |
| UK | 147,866 (88%) | 2.26 (0.64; 0.17,2.08) | 1.56 (0.44; 0.12,1.44) | 1.55 (0.44; 0.12,1.43) | 1.43 (0.41; 0.11,1.32) | 0.75 (0.31; 0.12,0.70) |
| U.S. | 101,428 (83%) | 1.42 (0.32; 0.05,1.24) | 0.99 (0.22; 0.03,0.86) | 0.98 (0.22; 0.03,0.85) | 0.9 (0.20; 0.03,0.79) | 0.31 (0.06; 0,0.27) |
| Total | 308,297 (83%) | 1.73 (0.42; 0.07,1.59) | 1.20 (0.29; 0.05,1.10) | 1.19 (0.29; 0.05,1.09) | 1.09 (0.27; 0.04,1.01) | 0.43 (0.10; 0,0.39) |
Notes. Values include doses recorded as zero. RBM = red bone marrow. IQR = interquartile range (25th percentile, 75th percentile).
The cohort includes 268,262 men and 40,035 women.